IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q3 2020 Holdings

Filed 2020-11-13 | 15 holdings | $84.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
ALX Oncology Holdings Inc.(ALXO)COM00166B105$36.7M973,51443.7%
Cytokinetics Incorporated(CYTK)COM23282W605$36.2M1,672,29243.0%
Arbutus Biopharma Corp(ABUS)COM03879J100$10.4M3,332,61612.4%
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$372.0K144,8740.4%
Relay Therapeutics, Inc.(RLAY)COM75943R102$91.1K2,139,3800.1%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$82.0K2,348,0140.1%
Keros Therapeutics, Inc.(KROS)COM492327101$54.5K1,412,7050.1%
Kura Oncology, Inc.(KURA)COM50127T109$40.1K1,307,9820.0%
Generation Bio Co.(GBIOGBX)COM37148K100$26.5K857,9390.0%
Vaxcyte, Inc.(PCVX)COM92243G108$23.0K465,8210.0%
Myokardia, Inc.COM62857M105$17.2K126,4920.0%
Cymabay Therapeutics, Inc.(CBAYUSD)COM23257D103$12.9K1,787,0940.0%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$5.5K516,7510.0%
Therapeutics Acquisition CorpCOM CL A88339T103$5.0K350,0000.0%
Panacea Acquisition CorpUNIT698102209$1.8K150,0000.0%